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Objective: We investigated whether innate differences in cytokine response were associated with the
absence of osteoarthritis (OA) in old age.
Design: In 82 participants from a cross-sectional birth cohort, radiographs of hands, hips and knees were
taken at the age of 90 years. OA was deﬁned as a KellgreneLawrence score of at least two. “Free from OA”
was deﬁned at patient level as absence of hip and knee OA, and presence of OA in maximally two hand
joints. The innate cytokine response was determined in whole-blood samples upon stimulation with
lipopolysaccharide. Logistic regression analyses were used to investigate associations between absence
of OA in relation to tertiles of interleukin (IL)-1b, IL-6, tumor necrosis factor (TNF)-a, IL-1 receptor
antagonist (RA) and IL-10. Adjustments were made for gender and body mass index.
Results: Sixteen percent of the participants were “free from OA”. Subjects in the lowest tertile of Il-1b
production had a 11-fold increased chance to be free of OA [odds ratio (OR) 11.3, conﬁdence intervals (CI)
95% 1.1e115.9], subjects in the lowest tertile of IL-6 production had an almost 7-fold increased chance to
be free of OA (OR 6.7, 95% CI 1.1e41.2). Absence of hand OA was associated with low innate production of
IL-6 and IL-1RA, absence of hip OA was associated with low innate IL-1b production. No associations
were found for TNF-a and IL-10.
Conclusions: Low innate capacity to produce the pro-inﬂammatory cytokines IL-1b and IL-6 is associated
with the absence of OA in old age.
 2010 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.Introduction
Osteoarthritis (OA) is the most prevalent joint disease and
a frequent cause of musculoskeletal disability in developed coun-
tries. It is not regarded as one distinct disease, but rather the result
of a complex interplay of predisposing hormonal, metabolic and
genetic factors, and local biomechanical factors, accounting for the
heterogeneity in OA phenotypes. Although age is generally
accepted as the strongest risk factor for OA, the prevalence and
incidence of OA decline after the seventh decade1,2. Few data areR.J. Goekoop, Department of
, Leiden, The Netherlands.
).
s Research Society International. Pavailable on the cause of this phenomenon2,3, but one could
hypothesize that factors exist that protect against OA.
Cytokine-driven anabolic and catabolic processes are involved
in the integrity of articular cartilage. Pro-inﬂammatory cytokines
have been demonstrated to play a pivotal role in the development
of the OA disease process. In particular, interleukin (IL)-1b and
tumor necrosis factor (TNF)-a seem to play a prominent role and
are of major importance to cartilage destruction and remodeling of
the subchondral bone4e10. Relatively large interindividual differ-
ences exist in the ex-vivo production of several cytokines upon the
same stimulus. These differences are caused by genetic factors as is
shown in twin studies11e13. The variation in DNA sequence that
explains these differences has not been identiﬁed yet. Thus the ex-
vivo production of cytokines is commonly used as an intermediate
phenotype to investigate associations between production of
cytokines and diseases such as OA.ublished by Elsevier Ltd. All rights reserved.
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effectively be performed in subjects without OA, moreover, in
subjects that would have had a high chance to develop OA. Since OA
is a slowly evolving disease, this type of study cannot be performed
in subjects of middle age or in subjects in their seventies, but rather
in old age, especially using the extreme phenotype of absence of OA
at very old age.
Therefore, we tested the hypothesis whether absence of OA at
90 years of age was associated with a low innate ex-vivo pro-
inﬂammatory cytokine production or high innate ex-vivo anti-
inﬂammatory cytokine production.
Method
Study population
In April 2004 all participants of the Leiden 85-plus Study (age
range 89e91) were invited to take part in the present subsidiary
study. The Leiden 85-plus Study is a prospective population based
follow-up study of all 85-year-old inhabitants of Leiden, The
Netherlands. The study design and characteristics of the cohort
were described in detail previously14. In short, between September
1997 and September 1999 all 705members of the 1912e1914 birth-
cohorts in the city of Leiden were invited to participate in the
month after their 85th birthday. The initial study cohort consisted
of 599 participants (87% response rate) at age 85 years. There was
no selection criterion related to health or demographic
characteristics.
All participants gave informed consent to enter the study but for
people who were severely cognitively impaired, a guardian gave
informed consent. The Medical Ethics Commission of Leiden
University approved the study.
Demographic and clinical characteristics
Demographic data and medical history were collected when
participants were aged 85 years. At the age of 90 years, a research
nurse visited participants at home and collected information by
questionnaire on demographic characteristics. The medical history,
regarding OA (“history of OA”) and co-morbid conditions were
obtained from participants’ general practitioners or nursing home
physicians by standardized interviews. When participants were 90
years their weight and heightweremeasured by the research nurse.
Radiographic examination and assessment of OA
Radiographic OA was chosen as phenotype since the aim of the
present study was to investigate etiology and pathogenesis. In
participants who were able to visit the hospital radiographs of
hands (dorso-volar), hips (anterioreposterior (AP), supine) and
knees (weight-bearing, posterioreanterior (PA), full-extension)
were obtained according to a standardized method with a ﬁxed
ﬁlm-focus distance and a ﬁxed position of the joint as was shown
before (submitted). Cognitive impairment was themajor reason not
to be able to come to the study center.
In short, radiographs were assessed for OA by two independent
readers (HMK and RJG), who were blinded to patient characteris-
tics. The method of scoring OA followed that described by Kellgren
and Lawrence (KeL) (score range 0e4)15. The following joints were
scored: eight distal interphalangal joints (DIPJs), eight proximal
interphalangal joints (PIPJs), two ﬁrst interphalangal joints (ﬁrst
IPJs) and two ﬁrst carpometocarpal joints (ﬁrst CMCJs), both hips
and both femoro-tibial joints.
The inter-observer reliability for a KeL 2 as a dichotomous
variable expressed by the k statistic varied from 0.88 for the righthip to 0.41 for the right ﬁrst IPJs. In cases of disagreement between
readers’ evaluation of the radiographic OA status of a joint, a rescore
was performed to reach consensus, which was used for
calculations.
OA diagnosis
OA for each joint was deﬁned as a KeL score 2. Overall pres-
ence of hand OA was deﬁned as a KeL score of 2 in three or more
joints of all scored hand joints. This cutoff was chosen since
radiological OA in one or two hand joints could be the result of
single traumatic lesions. This paper focuses on systemic patho-
physiology of OA, hence single lesions potentially due to trauma
alone are considered outside the scope of this paper. A participant
was considered “free from OA” when no OAwas present in the hips
and knees and hand OA was absent. A joint prosthesis in a partic-
ular joint was regarded as OA if this was the indication for the
operation. If the reasonwas unknown, the joint was not included in
the rating.
Cytokine production capacity of the innate immune system
At the age of 85 and 86 two venous blood samples were
drawn. The cytokine production capacity of the innate immune
system was assessed by stimulating ex-vivo whole-blood samples
with lipopolysaccharide (LPS) as described before16. Cytokine
production by this method is under tight genetic control and
production levels have been shown to be stable over time12,17. In
short, all venous blood samples were drawn in the morning,
diluted 2-fold with RPMI-1640, and stimulated with 10 ng/ml
Escherichia coli-derived LPS (Difco Laboratories, Detroit, MI, USA)
before 11.00 am to exclude circadian variation. After 4 h and after
24 h of incubation at 37C and 5% CO2, supernatants were
collected and stored at 80C to measure TNF-a and IL-1b, IL-6,
IL-10, and IL-1 receptor antagonist (RA), respectively. Standard
enzyme-linked immuno sorbent assay (ELISA) techniques were
performed according to the manufacturers’ guidelines (Central
Laboratory of the Blood Transfusion Service, Amsterdam, The
Netherlands). Three participants had unstimulated TNF-a produc-
tion >0.10 pg/ml and were thought to have a temporarily
inﬂammatory condition and were excluded from further analyses.
Participants did not use immunosuppressive drugs. Between test
agreement was 79% for both low and high producers (lowest and
highest tertiles of cytokine production of LPS stimulated IL-1b),
overall test agreement was moderate assessed by Cohen’s Kappa
(k¼ 0.51). The average of the two observations was used for
analyses.
Statistical analyses
Differences in demographic and clinical characteristics between
participants who were able to visit the study center for radio-
graphic examination vs those who were not, and between partici-
pants with OA vs those without OA were determined using
two-sided independent Student’s T-tests for continuous variables
and with Chi-square tests for non-continuous variables.
The mean difference in the innate ex-vivo production of cyto-
kines between participants with and without OA was calculated by
linear mixed models to take into account the two available levels
for every participant. A covariance pattern model was used with
body mass index (BMI), sex and their interaction in the matrix
model. Since the ex-vivo production of cytokines was not normally
distributed, a log transformationwas performed. Estimates of ﬁxed
effects were reported with 95% conﬁdence intervals (95% CI).
Adjustments were made for gender, BMI and patient-effect. The
Table I
Absence of OA in relation to tertiles of innate cytokine production
Cytokine,
tertiles
(pg/ml)
Absence of Free from OA
Hand OA Knee OA Hip OA
IL-1b
1.0e3.2 2.5 (0.7e9.2) 3.0 (0.8e10.4) 4.6 (1.1e18.5) 11.3 (1.1e115.9)
3.3e6.4 2.8 (0.8e10.7) 2.3 (0.6e8.2) 2.3 (0.6e8.5) 13.2 (1.3e136.6)
6.5e31.5 1.0 1.0 1.0 1.0
IL-6
29.8e51.8 8.7 (1.9e39.5) 1.6 (0.5e5.8) 2.0 (0.5e8.1) 6.7 (1.1e41.2)
51.9e73.8 4.2 (0.9e20.4) 1.4 (0.4e5.1) 1.2 (0.3e4.4) 3.3 (0.4e23.9)
73.9e112.1 1.0 1.0 1.0 1.0
TNF-a
5.7e9.3 1.0 (0.3e3.5) 1.9 (0.5e7.3) 2.0 (0.5e8.1) 1.3 (0.3e5.8)
9.4e12.1 0.6 (0.2e2.1) 0.5 (0.1e1.9) 0.9 (0.2e3.3) 0.3 (0.1e2.0)
12.2e18.5 1.0 1.0 1.0 1.0
IL-1RA
17.1e31.8 4.4 (1.1e18.0) 1.8 (0.5e6.6) 1.2 (0.3e4.4) 6.5 (0.95e44.5)
31.9e43.3 2.8 (0.7e10.9) 0.4 (0.1e1.5) 1.3 (0.3e4.8) 2.9 (0.5e18.7)
43.4e148.0 1.0 1.0 1.0 1.0
IL-10
0.37e0.70 1.7 (0.5e6.3) 2.2 (0.6e8.0) 2.0 (0.5e7.7) 3.2 (0.6e16.6)
0.71e0.88 2.3 (0.6e8.3) 0.8 (0.2e2.6) 1.5 (0.4e5.4) 2.2 (0.4e12.2)
0.89e1.99 1.0 1.0 1.0 1.0
OR’s (95% CI) represent the relative probability for participants to be “free from
(subtype) OA” compared to participants in the highest tertile of cytokine production,
adjusted for gender and BMI.
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innate ex-vivo production of cytokines between participants with
and without OA.
Subsequently, the association between the tertiles of cytokine
levels, based on the distribution in the participants, and absence of
OA was determined by logistic regression analysis. Odds ratios
(ORs) with 95% CI were calculated, presented within parentheses.
Adjustments were made for gender and BMI. All analyses were
carried out using statistical analysis software, SPSS version 16.0
(SPSS Inc, Chicago, Ill, USA).
Results
Study population
Two hundred and ninety-one 90-year-olds were alive at the
start of the present study. Of those, 258 (response 89%) were
willing to participate and were visited in their home in order to
collect data. Eighty-two (32%) participants were able to visit the
study center and underwent a radiographic examination (Fig. 1).
The majority of the study participants were women (74%) and,
overall, participants were slightly overweight (BMI 27.0 kg/m2).
The frequency of “history of OA”, derived from the general
practitioner as well as innate cytokine production levels were
equally distributed among those who were able and those who
were unable to come to the study center (range of P-values:
0.23e0.86).
Absence of OA at 90 years
Thirteen (15.9%) participants met the criteria “free from OA”.
Hand OA was absent in 24 (29.3%) participants. The majority of
participants had no knee (n¼ 42, 51.2%) nor hip (n¼ 52, 63.4%) OA.
Innate ex-vivo production of cytokines in 90-year-olds without OA
The mean difference between participants “free from OA”
compared to those with OA in innate ex-vivo production of IL-1b
was 3.1 (95% CI 0.7e6.6, P¼ 0.007) pg/ml lower in the former
group; IL-6 levels were 11.7 (95% CI 0.9e24.5, P¼ 0.03) pg/ml
lower; and IL-1RA levels were 8.1 (95% CI 1.5e16.2, P¼ 0.014) pg/ml
lower. The mean innate ex-vivo production of IL-10 and TNF-a did
not differ between the two groups.
Table I shows the association of the absence of OA in relation
to tertiles of innate ex-vivo cytokine production. The OR’s for “freeFig. 1. Flowfrom OA” was 11.2 [1.1e115.9] for participants in the lowest tertile
of IL-1b production, and 6.7 [1.1e41.2] for those in the lowest
tertile of IL-6 production (both in comparison to those in the
highest tertile). All calculations were adjusted for gender and BMI.
Furthermore, lower IL-1RA production was seen in absence of OA
(OR 6.5 [0.95e44.5]). No associations were found for IL-10 and
TNF-a.
The difference in cumulative distribution of innate cytokine
production levels of IL-1b, IL-6 and IL-1RA is depicted in Fig. 2.
Due to the heterogenic nature of OA, we investigated whether
these associations were joint site speciﬁc. Therefore, we compared
absence of individual joint site OA with tertiles of IL-1b, IL-6 and
IL-1RA production. The lowest tertiles of IL-6 and IL-1RA produc-
tion were both associated with the absence of hand OA (OR 8.7
[1.9e39.5] and OR 4.4 [1.1e18.0] respectively). The lowest tertile of
IL-1b productionwas associated with the absence of hip OA (OR 4.6
[1.1e18.5]).chart.
Fig. 2. Cumulative distribution of innate cytokine production levels of IL-1b, IL-6 and IL-1RA in participants “free from OA” (black dots) vs those with OA (open dots).
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The present study in 90-year-olds provides the ﬁrst evidence
that innate differences in the ex-vivo pro-inﬂammatory cytokine
production are associated with absence of OA in old age. Partici-
pants with low innate production of IL-1b and IL-6 were found to
have absence of OA more frequently, independent of gender and
BMI. Joint site speciﬁc differences were observed; absence of hand
OAwas associated with low production of IL-6 and IL-1RA; absence
of hip OA was associated with low production of IL-1b. No associ-
ations for IL-10 and TNF-a and absence of OA were demonstrated.
This unique cohort, in whom extensive radiographic, demo-
graphic, and immunologic data are available in 90-year-olds, gives
way to investigate protective mechanisms against OA and the
pathophysiology of OA in general. Population based studies
including a range of age groups demonstrate that the prevalence
and incidence of OA reaches a plateau or decrease above 70 years of
age18e21. Possible explanations for the ﬂattening of the prevalence
above 70 years of age could be preferred early mortality in indi-
viduals with OA, or the existence of protective genetic factors
against the development of OA that are associated with longevity.
Some studies did indeed found an increased mortality risk for
persons with OA22e24. In addition, genetic factors are thought to
inﬂuence survival and longevity as well as the development of OA.
So, genetic factors could possibly account for the observed
declining prevalence of OA at old age25. Previously we have shown
that a pro-inﬂammatory cytokine proﬁle or the lack of an anti-
inﬂammatory cytokine proﬁle is associated with cardiovascular
mortality or stroke respectively at old age26,27. Preferred mortality
as well as protective genetic factors are therefore the most likely
explanation for the observed ﬂattening of the prevalence of OA.
Differences in cytokine characteristics have been shown to be
associated with the incidence and progression of OA in epigenetic
(innate cytokine production) as well as genetic (gene cluster
polymorphisms) studies, suggesting a causal role in the patho-
genesis of OA. IL-1b and TNF-a can stimulate their own production
and induce chondrocytes and synovial cells to produce other
cytokines, such as IL-8, IL-6, and leukocyte inhibitory factor (LIF), as
well as stimulate proteases and prostaglandin E2 (PGE2) produc-
tion. Moreover, IL-1b and TNF-a have also been shown to induce
osteoclastic bone resorption in vitro, a phenomenon that may be
involved in the remodeling of OA subchondral bone5e7,9. Animal
studies have conﬁrmed the essential role of IL-1b in cartilage
destructive processes28. The role of IL-6 is less clear. It could
contribute to OA’s pathological process by (1) increasing the
number of inﬂammatory cells in synovial tissue (2) stimulating the
proliferation of chondrocytes; and (3) inducing an ampliﬁcation of
the IL-1 effects on the increased synthesis of matrix metal-
loproteases (MMP) and inhibiting proteoglycan production. In
contrast, as IL-6 can induce production of tissue inhibitors ofmetalloproteinase (TIMP), and not MMP, it could also be involved in
a feedback mechanism that limits proteolytic damage18,29.
In the current study, we show that innate differences in the
production of IL-1b and IL-6 are associated with the absence of OA
in old age. Low innate production of IL-1b is associated with
absence of OA, which is in line with the above mentioned studies.
IL-1b is a catabolic cytokine causing damage; therefore, one could
speculate that lower production of IL-1b to certain stimuli would
lead to a state inwhich “joint-survival” following stress and stimuli
is favored over “joint destruction”.
Furthermore, low innate production of IL-6 is associated with
the absence of OA, which is in inline with recent data on the
association of IL-6 promotor variants and DIP OA30. Indeed we did
see the strongest association for joint site speciﬁc OA and IL-6 in
absence of hand OA. Low IL-1RA production tends to be associated
with absence of OA, which is in line with our earlier observations at
middle age8. The role of IL-10 in OA is unclear, and based on the
current study, protection against OA is not the result of innate high
IL-10 production.
Different pathophysiological processes account for heteroge-
neity in OA phenotypes. Therefore, different phenotypes were
investigated for their individual association with innate cytokine
production. We found that absence of hand OAwas associated with
innate low production of IL-6 and IL-1RA and that absence of hip OA
was associated with low innate production of IL-1b. Associations
were stronger for hand OA, which is in line with the genetic data
from twin studies in OA that show that hand OA is more heritable
than hip or knee OA31,32.
This small hypothesis generating study has some potential
limitations that should be addressed. First, participants who
underwent radiographic examinations were a ‘convenience
sample’ of our wider study population. However, the use of
a ‘convenience sample’ did not inﬂuence the (general practitioner
derived) prevalence of “history of OA” between those with vs those
without radiographic examination. Nevertheless, we accept that
participants with a radiographic examination and without OA may
be overrepresented. This possible overrepresentation does
however not harm the purpose of our explorative study; to deter-
mine protective factors against OA rather than risk factors in
participants with OA. In fact an overrepresentation of absence of OA
would reduce the effect size of the OR’s. Second, the number of
participants who underwent radiographic examination was small
and therefore CIs are broad. Furthermore, it should be mentioned
that the OR’s overestimate true effect sizes in this small study with
a common outcome parameter. However, despite the small sample
size established risk factors, as well as new protective factors, for
OAwere statistically signiﬁcant. Importantly, whole-blood samples
were taken 5 years before determination of the phenotype. Since
the cytokine levels reﬂect the capacity of innate cytokine produc-
tion, which changes little over time16, this will not inﬂuence the
R.J. Goekoop et al. / Osteoarthritis and Cartilage 18 (2010) 942e947946results. Moreover, whole-blood samples were drawn at two
different time point (age 85 and 86 years) enabling the use of the
mean level of innate cytokine production, which strengthens our
observations.
In conclusion, our study provides the ﬁrst evidence that the low
innate production of the pro-inﬂammatory cytokines IL-1b and IL-6
is associated with the absence of OA in old age. Absence of hand OA
was associated with low IL-6 and low IL-1RA innate production and
absence of hip OAwas associated with low IL-1b production. These
ﬁndings suggest the presence of protective factors against OA
development and add to the body of evidence that cytokine path-
ways play a crucial, possibly causal, role in the pathophysiology of
OA in general.
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